What the Patent Data Reveals
This white paper delivers a data-driven comparison of two biologic modalities moving at very different stages of maturity. Drawing on more than 340,000 global patents analyzed at the patent-family level, it shows how ADCs are increasingly defined by lifecycle-driven refinement, while bispecific antibodies remain in a high-growth, exploratory phase marked by structural complexity and expanding IP whitespace.
Gain clarity on where innovation is genuinely accelerating, which formats are shaping future pipelines, and how geographic and jurisdictional choices are influencing long-term IP value.
Nearly 15% of all bispecific patent applications were published in 2025 alone, underscoring how rapidly this landscape is expanding compared with ADCs.
Together, these insights provide a clear lens into who is driving momentum, where competitive pressure is building, and how companies are using next-generation formats to extend exclusivity and defend strategic targets.
Created for Strategic Decision-Makers
Powered by Beacon’s global patents database, this white paper goes beyond raw filing counts to reveal portfolio depth, grant behavior, jurisdictional value, and long-term lifecycle risk, the signals that matter when shaping R&D, licensing, and competitive strategy.
Download the full white paper to understand where ADCs and bispecifics are diverging today, and how they are converging strategically for the future.
Recent Content
Beacon Data Solutions for Complex Therapies and Diseases
Beacon ADC
Complete transparency into the ADC drug development landscape
- Unrivalled comprehensive & accurate preclinical & clinical ADC drug, trial and commercial data
- Access to 3,800+ Drugs, 4,300+ Trials, 2,500+ Companies, and 3,000+ Deals in the ADC space
- Market leading ontologies, enabling precise navigation of specific ADC technologies
- Manually curated by ADC scientists, with data updated daily
Beacon Autoimmune
Complete transparency into the Autoimmune drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Autoimmune drug, trial and commercial data
- Access to 7,000+ Drugs, 14,500+ Trials, 7,200+ Companies, and 9,200+ Deals in the Autoimmune space
- Market leading ontologies, enabling precise navigation of specific Autoimmune therapies
- Manually curated by Autoimmune scientists, with data updated daily
Beacon Bispecific
Complete transparency into the Bispecific drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Bispecific therapeutic drug, trial and commercial data
- Access to 3,500+ Drugs, 3,200+ Trials, 2,400+ Companies, and 2,800+ Deals in the Bispecific space
- Market leading ontologies, enabling precise navigation of specific Bispecifics
- Manually curated by Bispecific scientists, with data updated daily
Beacon Cancer Vaccine
Complete transparency into the Cancer Vaccine development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cancer Vaccine drug, trial and commercial data
- Access to 1,800+ Drugs, 1,800+ Trials, 1,600+ Companies, and 1,800+ Deals in the Cancer Vaccine space
- Market leading ontologies, enabling precise navigation of specific Cancer Vaccines
- Manually curated by Cancer Vaccine scientists, with data updated daily
Beacon Cell Therapy
Complete transparency into the Cell Therapy development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cell Therapy drug, trial and commercial data
- Access to 8,100+ Drugs, 6,500+ Trials, 3,700+ Companies, and 4,700+ Deals in the Cell Therapy space
- Market leading ontologies, enabling precise navigation of specific Cell Therapies
- Manually curated by Cell Therapy scientists, with data updated daily
Beacon Checkpoint
Complete transparency into the Checkpoint drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Checkpoint drug, trial and commercial data
- Access to 2,500+ Drugs, 16,600+ Trials, 2,500+ Companies, and 3,300+ Deals in the Checkpoint space
- Market leading ontologies, enabling precise navigation of specific Checkpoint therapeutics
- Manually curated by Checkpoint scientists, with data updated daily
Beacon Cytokine
Complete transparency into the Cytokine drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Cytokine drug, trial and commercial data
- Access to 3,500+ Drugs, 11,200+ Trials, 3,700+ Companies, and 4,300+ Deals in the Cytokine space
- Market leading ontologies, enabling precise navigation of specific Cytokine targeting therapies
- Manually curated by Cytokine scientists, with data updated daily
Beacon DDR
Complete transparency into the DDR drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical DDR drug, trial and commercial data
- Access to 900+ Drugs, 2,100+ Trials, 1,100+ Companies, and 1,100+ Deals in the DDR space
- Market leading ontologies, enabling precise navigation of the DDR drug development landscape
- Manually curated by DDR scientists, with data updated daily
Beacon Gene Therapy
Complete transparency into the Gene Therapy drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Gene Therapy drug, trial and commercial data
- Access to 2,800+ Drugs, 1,300+ Trials, 2,000+ Companies, and 2,300+ Deals in the Gene Therapy space
- Market leading ontologies, enabling precise navigation of specific Gene Therapies
- Manually curated by Gene Therapy scientists, with data updated daily
Beacon Microbiome
Complete transparency into the Microbiome drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Microbiome drug, trial and commercial data
- Access to 1,300+ Drugs, 1,200+ Trials, 1,100+ Companies, and 900+ Deals in the Microbiome space
- Market leading ontologies, enabling precise navigation of the Microbiome drug development landscape
- Manually curated by Microbiome scientists, with data updated daily
Beacon Neurology
Complete transparency into the Neurology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neurology drug, trial and commercial data
- Access to 7,600+ Drugs and 9,100+ Trials, 5,600+ Companies, and 4,700+ Deals in the Neurology space since 2011
- Market leading ontologies, enabling precise navigation of the Neurology drug development landscape
- Manually curated by Neurology scientists, with data updated daily
Beacon Neuroscience
Complete transparency into the Neuroscience drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Neuroscience drug, trial and commercial data
- Access to 9,000+ Drugs, 14,000+ Trials, 5,600+ Companies, and 4,700+ Deals in the Neuroscience space since 2011
- Market leading ontologies, enabling precise navigation of the Neuroscience drug development landscape
- Manually curated by Neuroscience scientists, with data updated daily
Beacon Oncology
Complete transparency into the Oncology drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncology drug, trial and commercial data
- Access to 28,000+ Drugs, 54,000+ Trials, 9,400+ Companies, and 16,300+ Deals in the Oncology space
- Market leading ontologies, enabling precise navigation of the Oncology drug development landscape
- Manually curated by Oncology scientists, with data updated daily
Beacon Oncolytic Viruses
Complete transparency into the Oncolytic Viruses drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Oncolytic Virus drug, trial and commercial data
- Access to 750+ Drugs, 650+ Trials, 650+ Companies, and 650+ Deals in the Oncolytic Virus space
- Market leading ontologies, enabling precise navigation of specific Oncolytic Virus’
- Manually curated by Oncolytic Virus scientists, with data updated daily
Beacon Psychiatric
Complete transparency into the Psychiatric drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical Psychiatric drug and trial data
- Access to 1,700+ Drugs and 5,200+ Trials in the Psychiatric space since 2011
- Market leading ontologies, enabling precise navigation of the Psychiatric drug development landscape
- Manually curated by Psychiatric scientists, with data updated daily
Beacon RNA
Complete transparency into the RNA drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical RNA therapeutic drug, trial and commercial data
- Access to 5,800+ Drugs, 2,700+ Trials, 3,400+ Companies, and 4,100+ Deals in the RNA Therapeutic space
- Market leading ontologies, enabling precise navigation of specific RNA therapeutics
- Manually curated by RNA scientists, with data updated daily
Beacon TPD
Complete transparency into the TPD drug development landscape
- Unrivalled comprehensive & accurate preclinical and clinical TPD drug, trial and commercial data
- Access to 2,400+ Drugs, 4,466+ Trials, 1,600+ Companies, and 1,500+ Deals in the TPD space
- Market leading ontologies, enabling precise navigation of the TPD drug development landscape
- Manually curated by TPD scientists, with data updated daily
Learn More About ADC
- The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
- Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
